Figure 2: Survival curve for patients subdivided on the basis of lymph node status. A, When lymph node negative, the 5-year survival point for patients with weak ANXA7 was 100%, whereas only 77% of patients with moderate ANXA7 expression survived, and 55% of patients with strong ANXA7 expression survived. B, survival curve for patients subdivided on the basis of ANX7 expression and lymph node positive. At the 5-year survival point, weak ANXA7 expression predicts 100% survival, whereas moderate ANXA7 expression predicts only 46% survival and none survived at high ANXA7 expression.